Genenta Strengthens Senior Management With Key Strategic Appointments
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Genenta Strengthens Senior Management With Key Strategic Appointments
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Share:
MILAN, Italy and NEW YORK, May 10, 2021 (GLOBE NEWSWIRE) Genenta Science, a clinical-stage biotechnology company pioneering the development of a hematopoietic stem cell gene therapy for cancer (Temferon™), announced it will be presenting at several upcoming scientific congresses in May and June.
Details of the presentations are as follows:
American Society of Cell and Gene Therapy (ASGCT) 24
th Annual Meeting, May 11-14, virtual
Title: Changes in the Tumor Microenvironment in Patients with Glioblastoma Multiforme Treated with IFN-a Immune Cell & Gene Therapy (TEM-GBM 001 Study)
Type: Oral presentation
2021 American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8, virtual
Title: A phase I-IIa study of genetically modified Tie-2 expressing monocytes in patients with glioblastoma multiforme (TEM-GBM Study)